uri,term,definition,alternative term
http://purl.obolibrary.org/obo/CHEBI_38830,1-benzofurans,A member of the class of benzofurans consisting of a 1-benzofuran skeleton and its substituted derivatives thereof.,None
http://purl.obolibrary.org/obo/CHEBI_17980,3'-phospho-5'-adenylyl sulfate,An adenosine bisphosphate having monophosphate groups at the 3'- and 5'-positions and a sulfo group attached to the phosphate at position 5'.,None
http://purl.obolibrary.org/obo/CHEBI_59613,4'-hydroxydiclofenac,A monocarboxylic acid that is the 4'-hydroxylated metabolite of diclofenac.,None
http://purl.obolibrary.org/obo/CHEBI_63840,5'-hydroxyomeprazole,A sulfoxide that is omeprazole in which one of the methyl hydrogens at position 5 on the pyridine ring is substituted by a hydroxy group.,None
http://purl.obolibrary.org/obo/CHEBI_82814,"5-[2-(dimethylamino)ethyl]-2-(4-methoxyphenyl)-4-oxo-2,3,4,5-tetrahydro-1,5-benzothiazepin-3-yl acetate","A lactam that is 2,3-dihydro-1,5-benzothiazepin-4(5H)-one in which positions 2 and 3 are substituted by 4-methoxyphenyl and acetoxy, respectively, while the hydrogen attached to the nitrogen is substituted by a 2-(dimethylamino)ethyl group.",None
http://purl.obolibrary.org/obo/CHEBI_34480,7-ethoxyresorufin,None,None
http://purl.obolibrary.org/obo/CLO_0002421,CHO cell,None,CHO
http://purl.obolibrary.org/obo/CLO_0002421,CHO cell,None,Chinese Hamster Ovary cell
http://purl.obolibrary.org/obo/CLO_0002172,Caco-2 cell,None,Caco-2
http://purl.obolibrary.org/obo/NCBITaxon_562,Escherichia coli,None,None
http://purl.obolibrary.org/obo/NCBITaxon_9606,Homo sapiens,None,human
http://purl.obolibrary.org/obo/NCBITaxon_9606,Homo sapiens,None,man
http://purl.obolibrary.org/obo/NCBITaxon_9606,Homo sapiens,None,human being
http://purl.obolibrary.org/obo/CHEBI_6931,Midazolam,None,None
http://purl.obolibrary.org/obo/CHEBI_13389,NAD,Abbreviation for nicotinamide-adenine dinucleotide when its oxidation state is unknown or unspecified. It is used in metabolic pathways like glycolysis and citric acid cycle.,None
http://purl.obolibrary.org/obo/CHEBI_16908,NADH,"A coenzyme found in all living cells; consists of two nucleotides joined through their 5'-phosphate groups, with one nucleotide containing an adenine base and the other containing nicotinamide.",None
http://purl.obolibrary.org/obo/CHEBI_16474,NADPH,"NADPH is the reduced form of NADP+; used in anabolic reactions, such as lipid and nucleic acid synthesis, which require NADPH as a reducing agent.",None
http://purl.obolibrary.org/obo/FMA_9669,Portion of body substance,"Material anatomical entity in a gaseous, liquid, semisolid or solid state, with or without the admixture of cells and biological macromolecules; produced by anatomical structures or derived from inhaled and ingested substances that have been modified by anatomical structures. Examples: saliva, semen, cerebrospinal fluid, respiratory air, urine, feces, blood, plasma, lymph.",None
http://purl.obolibrary.org/obo/FMA_62970,Portion of plasma,"Body substance in liquid state contained in the lumen of arterial and venous trees, blood capillary and the cardiac chambers; constitutes the liquid phase of blood.",None
http://purl.obolibrary.org/obo/ERO_0001206,RNA interference oligonucleotide,"An RNA interference reagent used to silence expression of a target gene in cells, through the RNA interference pathway.",RNAi oligonucleotide
http://purl.obolibrary.org/obo/ERO_0001205,RNA oligonucleotide,"An RNA reagent consisting of a short, linear RNA polymer, typically with 100 or fewer bases.",RNA oligo
http://purl.obolibrary.org/obo/ERO_0001202,RNA reagent,A reagent that is a polymer comprised of RNA nucleotides.,None
http://purl.obolibrary.org/obo/CHEBI_17200,UDP-alpha-D-glucuronic acid,A UDP-sugar having alpha-D-glucuronic acid as the sugar component.,None
http://purl.obolibrary.org/obo/CHMO_0002914,absorption of material,The process of one material (absorbate) being retained by another (absorption).,None
http://purl.obolibrary.org/obo/PDRO/PDRO.owl#PDRO_0000124,active ingredient quantification specification,A dose quantification specification that quantifies a dose by referring to the quantity of active ingredient administered in a dose administration.,None
http://purl.obolibrary.org/obo/CHEBI_35217,alkaline earth coordination entity,None,None
http://purl.obolibrary.org/obo/CHEBI_2663,amiodarone,An organoiodine compound that has formula C25H29I2NO3.,None
http://purl.obolibrary.org/obo/UBERON_0000467,anatomical system,"Multicellular, connected anatomical structure that has multiple organs as parts and whose parts work together to achieve some shared function.",None
http://purl.obolibrary.org/obo/CHEBI_39548,atorvastatin,"A dihydroxy monocarboxylic acid that is a member of the drug class known as statins, used primarily for lowering blood cholesterol and for preventing cardiovascular diseases.",None
http://purl.obolibrary.org/obo/CHEBI_68452,azole,"Any monocyclic heteroarene consisting of a five-membered ring containing nitrogen. Azoles can also contain one or more other non-carbon atoms, such as nitrogen, sulfur or oxygen.",None
http://purl.obolibrary.org/obo/CHEBI_22715,benzimidazoles,An organic heterocyclic compound containing a benzene ring fused to an imidazole ring.,None
http://purl.obolibrary.org/obo/CHEBI_35259,benzofurans,None,None
http://purl.obolibrary.org/obo/CHEBI_48684,benzothiazepine,None,None
http://purl.obolibrary.org/obo/GO_0065007,biological regulation,"Any process that modulates a measurable attribute of any biological process, quality or function.",None
http://purl.obolibrary.org/obo/CHEBI_24432,biological role,A role played by the molecular entity or part thereof within a biological context.,None
http://purl.obolibrary.org/obo/GO_0008150,biological_process,"Any process specifically pertinent to the functioning of integrated living units: cells, tissues, organs, and organisms. A process is a collection of molecular events with a defined beginning and end.",None
http://purl.obolibrary.org/obo/CHEBI_33694,biomacromolecule,A macromolecule formed by a living organism.,None
http://purl.obolibrary.org/obo/OGMS_0000060,bodily process,None,None
http://purl.obolibrary.org/obo/CHEBI_33582,carbon group molecular entity,None,None
http://purl.obolibrary.org/obo/CHEBI_35605,carbon oxoacid,None,None
http://purl.obolibrary.org/obo/CHEBI_33575,carboxylic acid,"A carbon oxoacid acid carrying at least one -C(=O)OH group and having the structure RC(=O)OH, where R is any any monovalent functional group. Carboxylic acids are the most common type of organic acid.",None
http://purl.obolibrary.org/obo/CHEBI_33308,carboxylic ester,"An ester of a carboxylic acid, R(1)C(=O)OR(2), where R(1) = H or organyl and R(2) = organyl.",None
http://purl.obolibrary.org/obo/GO_0003824,catalytic activity,"Catalysis of a biochemical reaction at physiological temperatures. In biologically catalyzed reactions, the reactants are known as substrates, and the catalysts are naturally occurring macromolecular substances known as enzymes. Enzymes possess specific binding sites for substrates, and are usually composed wholly or largely of protein, but RNA that has catalytic activity (ribozyme) is often also regarded as enzymatic.",None
http://purl.obolibrary.org/obo/CLO_0000001,cell line cell,"A cultured cell that is part of a cell line - a stable and homogeneous population of cells with a common biological origin and propagation history in culture
",None
http://purl.obolibrary.org/obo/CLO_0000001,cell line cell,A cultured cell that is part of a cell line - a stable and homogeneous population of cells with a common biological origin and propagation history in culture,None
http://purl.obolibrary.org/obo/GO_0044237,cellular metabolic process,The chemical reactions and pathways by which individual cells transform chemical substances.,None
http://purl.obolibrary.org/obo/GO_0005575,cellular_component,"The part of a cell or its extracellular environment in which a gene product is located. A gene product may be located in one or more parts of a cell and its location may be as specific as a particular macromolecular complex, that is, a stable, persistent association of macromolecules that function together.",None
http://purl.obolibrary.org/obo/CHEBI_59999,chemical substance,"A chemical substance is a portion of matter of constant composition, composed of molecular entities of the same type or of different types.",None
http://purl.obolibrary.org/obo/OBI_0000967,container,A device that can be used to restrict the location of material entities over time,None
http://purl.obolibrary.org/obo/CHEBI_33240,coordination entity,An assembly consisting of a central atom (usually metallic) to which is attached a surrounding array of other groups of atoms (ligands).,None
http://purl.obolibrary.org/obo/CL_0000010,cultured cell,A cell in vitro that is or has been maintained or propagated as part of a cell culture.,None
http://purl.obolibrary.org/obo/OBI_0100060,cultured cell population,A processed material comprised of a collection of cultured cells that has been continuously maintained together in culture and shares a common propagation history.,cell culture sample
http://purl.obolibrary.org/obo/CHEBI_38559,cytochrome P450,None,None
http://purl.obolibrary.org/obo/MOP_0001385,deethylation,Breaking of a covalent bond between a substrate and an ethyl group.,None
http://purl.obolibrary.org/obo/MOP_0000590,dehydrogenation,"An oxidation process that involves the removal of adjacent hydrogen atoms, resulting in an increase of bond order.",None
http://purl.obolibrary.org/obo/CHEBI_18946,delta-lactone,A lactone having a six-membered lactone ring.,None
http://purl.obolibrary.org/obo/MOP_0001364,demethylation,Breaking of a covalent bond between a substrate and a methyl group.,None
http://purl.obolibrary.org/obo/OBI_0000968,device,"A material entity that is designed to perform a function in a scientific investigation, but is not a reagent.",instrument
http://purl.obolibrary.org/obo/CHEBI_4470,dextromethorphan,An  organic heterotetracyclic compound that is morphinan substituted by a methoxy group at position 3 and a methyl group at position 7. It is used as an  antitussive drug for suppressing cough.,None
http://purl.obolibrary.org/obo/CHEBI_29133,dextrorphan,None,None
http://purl.obolibrary.org/obo/CHEBI_23677,diazole,An azole that is either one of a pair of heterocyclic organic compounds comprising three carbon atoms and two nitrogen atoms arranged in a ring.,None
http://purl.obolibrary.org/obo/CHEBI_47381,diclofenac,"A monocarboxylic acid consisting of phenylacetic acid having a (2,6-dichlorophenyl)amino group at the 2-position.",None
http://purl.obolibrary.org/obo/UBERON_0001007,digestive system,None,None
http://purl.obolibrary.org/obo/CHEBI_35972,dihydroxy monocarboxylic acid,None,None
http://purl.obolibrary.org/obo/CHEBI_101278,diltiazem,"A 5-[2-(dimethylamino)ethyl]-2-(4-methoxyphenyl)-4-oxo-2,3,4,5-tetrahydro-1,5-benzothiazepin-3-yl acetate in which both stereocentres have S configuration. A calcium-channel blocker and vasodilator, it is used as the hydrochloride in the management of angina pectoris and hypertension.",None
http://purl.obolibrary.org/obo/UO_0000186,dimensionless unit,A unit which is a standard measure of physical quantity consisting of only a numerical number without any units.,None
http://purl.obolibrary.org/obo/PDRO/PDRO.owl#PDRO_0000123,dose quantification specification,An information content entity that specifies how a dose is quantified in a dose administration.,None
http://purl.obolibrary.org/obo/OBI_0000969,dose specification,a directive information entity that describes the dose that will be administered to a target,None
http://purl.obolibrary.org/obo/PDRO/PDRO.owl#PDRO_0000125,drug product quantification specification,A dose quantification specification that quantifies a dose by referring to the quantity of drug product administered in a dose administration.,None
http://purl.obolibrary.org/obo/IDO_0100872,enzyme substrate role,"A role that inheres in a protein or a compound upon which enzyme catalyzes. It is realized in the enzymatic reaction processes, where the molecules at the beginning of the process, called substrates, are converted into different molecules, called products.",None
http://purl.obolibrary.org/obo/GO_0051234,establishment of localization,"Any process that localizes a substance or cellular component. This may occur via movement, tethering or selective degradation.",None
http://purl.obolibrary.org/obo/CHEBI_35701,ester,"A compound formally derived from an oxoacid RkE(=O)l(OH)m (l > 0) and an alcohol, phenol, heteroarenol, or enol by linking with formal loss of water from an acidic hydroxy group of the former and a hydroxy group of the latter.",None
http://purl.obolibrary.org/obo/CL_0000578,experimentally modified cell in vitro,A cell in vitro that has undergone physical changes as a consequence of a deliberate and specific experimental procedure.,None
http://purl.obolibrary.org/obo/CHEBI_46081,fluconazole,"A member of the class of  triazoles that is propan-2-ol substituted at position 1 and 3 by 1H-1,2,4-triazol-1-yl groups and at position 2 by a 2,4-difluorophenyl group. It has been shown to exhibit antifungal activity.",None
http://purl.obolibrary.org/obo/CHEBI_38561,fluvastatin,"A racemate comprising equimolar amounts of (3R,5S)- and (3S,5R)-fluvastatin. An HMG-CoA reductase inhibitor, it is used (often as the corresponding sodium salt) to reduce triglycerides and LDL-cholesterol, and increase HDL-chloesterol, in the treatment of hyperlipidaemia.",None
http://purl.obolibrary.org/obo/INO_0000102,gene expression,a biological interaction that uses the information from a gene to synthesize a functional gene product. ,None
http://www.ebi.ac.uk/efo/EFO_0000750,genotyping,None,None
http://purl.obolibrary.org/obo/CHEBI_16856,glutathione,A tripeptide compound consisting of glutamic acid attached via its side chain to the N-terminus of cysteinylglycine.,None
http://purl.obolibrary.org/obo/OBI_0001180,half maximal effective concentration (EC50),"half maximal effective concentration (EC50) is a scalar measurement datum corresponding to the concentration of a compound which induces a response halfway between the baseline and maximum after some specified exposure time. 
",None
http://purl.obolibrary.org/obo/OBI_0001191,half maximal inhibitory concentration (IC50),"Half maximal inhibitory concentration (IC50) is a scalar measurement datum that measures the effectiveness of a compound to competitively inhibit a given process, and corresponds to the concentration of the compound at which it reaches half of its maximum inhibitory effect.",None
http://purl.obolibrary.org/obo/CHEBI_36074,heme-thiolate protein,None,None
http://purl.obolibrary.org/obo/CHEBI_35137,hemoprotein,Conjugated proteins containing heme as the prosthetic group.,None
http://purl.obolibrary.org/obo/CHEBI_33833,heteroarene,"A heterocyclic compound formally derived from an arene by replacement of one or more methine (-C=) and/or vinylene (-CH=CH-) groups by trivalent or divalent heteroatoms, respectively, in such a way as to maintain the continuous pi-electron system characteristic of aromatic systems and a number of out-of-plane pi-electrons corresponding to the Hueckel rule (4n+2).",None
http://purl.obolibrary.org/obo/CHEBI_37577,heteroatomic molecular entity,A molecular entity consisting of two or more chemical elements.,None
http://purl.obolibrary.org/obo/CHEBI_33285,heteroorganic entity,A heteroorganic entity is an organic molecular entity in which carbon atoms or organic groups are bonded directly to one or more heteroatoms.,None
http://purl.obolibrary.org/obo/CHEBI_24669,hydroxy carboxylic acid,Any carboxylic acid with at least one hydroxy group.,None
http://purl.obolibrary.org/obo/CHEBI_35868,hydroxy monocarboxylic acid,None,None
http://purl.obolibrary.org/obo/MOP_0000673,hydroxylation,Formation of a covalent bond between a substrate and a hydroxy group.,None
http://purl.obolibrary.org/obo/CHEBI_24780,imidazoles,"A five-membered organic heterocycle containing two nitrogen atoms at positions 1 and 3, or any of its derivatives; compounds containing an imidazole skeleton.",None
http://purl.obolibrary.org/obo/GO_0019814,immunoglobulin complex,"A protein complex that in its canonical form is composed of two identical immunoglobulin heavy chains and two identical immunoglobulin light chains, held together by disulfide bonds and sometimes complexed with additional proteins. An immunoglobulin complex may be embedded in the plasma membrane or present in the extracellular space, in mucosal areas or other tissues, or circulating in the blood or lymph.",None
http://purl.obolibrary.org/obo/GO_0042571,"immunoglobulin complex, circulating","An immunoglobulin complex that is secreted into extracellular space and found in mucosal areas or other tissues or circulating in the blood or lymph. In its canonical form, a circulating immunoglobulin complex is composed of two identical heavy chains and two identical light chains, held together by disulfide bonds. Some forms of are polymers of the basic structure and contain additional components such as J-chain and the secretory component.",None
http://purl.obolibrary.org/obo/GO_0098739,import across plasma membrane,"The directed movement of some substance from outside of a cell, across the plasma membrane and into the cytosol.",None
http://purl.obolibrary.org/obo/GO_0098657,import into cell,The directed movement of some substance from outside of a cell into the cytoplasmic compartment. This may occur via transport across the plasma membrane or via endocytosis.,None
http://purl.obolibrary.org/obo/CHEBI_33695,information biomacromolecule,None,None
http://purl.obolibrary.org/obo/CHEBI_35222,inhibitor,A substance that diminishes the rate of a chemical reaction.,None
http://purl.obolibrary.org/obo/CHEBI_35136,iron protein,None,None
http://purl.obolibrary.org/obo/CHEBI_6076,itraconazole,A dioxolane that has formula C35H38Cl2N8O4.,None
http://purl.obolibrary.org/obo/CHEBI_48339,ketoconazole,A N-carbonylpiperazine that has formula C26H28Cl2N4O4.,None
http://purl.obolibrary.org/obo/CHEBI_25000,lactone,"Any cyclic carboxylic ester containing a 1-oxacycloalkan-2-one structure, or an analogue having unsaturation or heteroatoms replacing one or more carbon atoms of the ring.",None
http://purl.obolibrary.org/obo/GO_0051179,localization,"Any process in which a cell, a substance, or a cellular entity, such as a protein complex or organelle, is transported, tethered to or otherwise maintained in a specific location. In the case of substances, localization may also be achieved via selective degradation.",None
http://purl.obolibrary.org/obo/CHEBI_40303,lovastatin,A fatty acid ester that is mevastatin carrying an additional methyl group on the carbobicyclic skeleton. It is used in as a antilipemic drug and has been found in fungal species such as Aspergillus terreus and Pleurotus ostreatus (oyster mushroom).,None
http://purl.obolibrary.org/obo/GO_0032991,macromolecular complex,"A stable assembly of two or more macromolecules, i.e. proteins, nucleic acids, carbohydrates or lipids, in which the constituent parts function together.",None
http://purl.obolibrary.org/obo/CHEBI_33839,macromolecule,"A macromolecule is a molecule of high relative molecular mass, the structure of which essentially comprises the multiple repetition of units derived, actually or conceptually, from molecules of low relative molecular mass.",None
http://purl.obolibrary.org/obo/CHEBI_33976,magnesium coordination entity,None,None
http://purl.obolibrary.org/obo/CHEBI_6636,magnesium dichloride,A magnesium salt comprising of two chlorine atoms bound to a magnesium atom.,None
http://purl.obolibrary.org/obo/CHEBI_51234,magnesium halide,None,None
http://purl.obolibrary.org/obo/CHEBI_33579,main group molecular entity,"A molecular entity containing one or more atoms from any of groups 1, 2, 13, 14, 15, 16, 17, and 18 of the periodic table.",None
http://purl.obolibrary.org/obo/CHEBI_36562,main-group coordination entity,"A coordination entity in which the central atom to which the ligands are attached comes from groups 1, 2, 13, 14, 15, 16, 17, or 18 of the periodic table.",None
http://purl.obolibrary.org/obo/OBI_0000571,manufacturer role,Manufacturer role is a role which inheres in a person or organization and which is realized by a manufacturing process.,None
http://purl.obolibrary.org/obo/UBERON_0000465,material anatomical entity,Anatomical entity that has mass.,None
http://purl.obolibrary.org/obo/GO_0008152,metabolic process,"The chemical reactions and pathways, including anabolism and catabolism, by which living organisms transform chemical substances. Metabolic processes typically transform small molecules, but also include macromolecular processes such as DNA repair and replication, and protein synthesis and degradation.",None
http://purl.obolibrary.org/obo/CHEBI_25212,metabolite,Any intermediate or product resulting from metabolism. The term 'metabolite' subsumes the classes commonly known as primary and secondary metabolites.,None
http://purl.obolibrary.org/obo/CHEBI_35134,metalloprotein,None,None
http://purl.obolibrary.org/obo/CHEBI_60004,mixture,"A mixture is a chemical substance composed of multiple molecules, at least two of which are of a different kind.",None
http://purl.obolibrary.org/obo/CHEBI_23367,molecular entity,"Any constitutionally or isotopically distinct atom, molecule, ion, ion pair, radical, radical ion, complex, conformer etc., identifiable as a separately distinguishable entity.",None
http://purl.obolibrary.org/obo/GO_0003674,molecular_function,"Elemental activities, such as catalysis or binding, describing the actions of a gene product at the molecular level. A given gene product may exhibit one or more molecular functions.",None
http://purl.obolibrary.org/obo/CHEBI_38179,monocyclic heteroarene,None,None
http://purl.obolibrary.org/obo/GO_0048519,negative regulation of biological process,"Any process that stops, prevents, or reduces the frequency, rate or extent of a biological process. Biological processes are regulated by many means; examples include the control of gene expression, protein modification or interaction with a protein or substrate molecule.",None
http://purl.obolibrary.org/obo/GO_0009892,negative regulation of metabolic process,"Any process that stops, prevents, or reduces the frequency, rate or extent of the chemical reactions and pathways within a cell or an organism.",None
http://purl.obolibrary.org/obo/GO_0051051,negative regulation of transport,"Any process that stops, prevents, or reduces the frequency, rate or extent of the directed movement of substances (such as macromolecules, small molecules, ions) into, out of or within a cell, or between cells, by means of some agent such as a transporter or pore.",None
http://purl.obolibrary.org/obo/GO_0032410,negative regulation of transporter activity,Any process that stops or reduces the activity of a transporter.,None
http://purl.obolibrary.org/obo/CHEBI_33696,nucleic acid,"A macromolecule made up of nucleotide units and hydrolysable into certain pyrimidine or purine bases (usually adenine, cytosine, guanine, thymine, uracil), D-ribose or 2-deoxy-D-ribose and phosphoric acid.",None
http://purl.obolibrary.org/obo/ERO_0000630,nucleic acid reagent,"Reagent that is a polymer comprised of nucleotides, each of which consists of three components: a nitrogenous heterocyclic base, which is either a purine or a pyrimidine; a pentose sugar; and a phosphate group.",None
http://purl.obolibrary.org/obo/CHEBI_7772,omeprazole,A racemate comprising equimolar amounts of (R)- and (S)-omeprazole.,None
http://purl.obolibrary.org/obo/CHEBI_33832,organic cyclic compound,Any organic molecule that consists of atoms connected in the form of a ring.,None
http://purl.obolibrary.org/obo/CHEBI_27171,organic heterobicyclic compound,None,None
http://purl.obolibrary.org/obo/CHEBI_24532,organic heterocyclic compound,A cyclic compound having as ring members atoms of carbon and at least of one other element.,None
http://purl.obolibrary.org/obo/CHEBI_38166,organic heteropolycyclic compound,None,None
http://purl.obolibrary.org/obo/CHEBI_38163,organic heterotetracyclic compound,None,None
http://purl.obolibrary.org/obo/CHEBI_26979,organic heterotricyclic compound,An organic tricyclic compound in which at least one of the rings of the tricyclic skeleton contains one or more heteroatoms.,None
http://purl.obolibrary.org/obo/CHEBI_50860,organic molecular entity,Any molecular entity that contains carbon.,None
http://purl.obolibrary.org/obo/CHEBI_72695,organic molecule,Any molecule that consists of at least one carbon atom as part of the electrically neutral entity.,None
http://purl.obolibrary.org/obo/CHEBI_36962,organochalcogen compound,An organochalcogen compound is a compound containing at least one carbon-chalcogen bond.,None
http://purl.obolibrary.org/obo/CHEBI_36963,organooxygen compound,An organochalcogen compound containing at least one carbon-oxygen bond.,None
http://purl.obolibrary.org/obo/INO_0000114,overexpression,a gene expression that has increased volume. ,increased gene expression
http://purl.obolibrary.org/obo/INO_0000114,overexpression,a gene expression that has increased volume. ,overexpression
http://purl.obolibrary.org/obo/CHEBI_33675,p-block molecular entity,A p-block molecular entity is a molecular entity containing one or more atoms of a p-block element.,None
http://purl.obolibrary.org/obo/OGMS_0000061,pathological bodily process,A bodily process that is clinically abnormal.,None
http://purl.obolibrary.org/obo/UO_0000187,percent,A dimensionless ratio unit which denotes numbers as fractions of 100.,None
http://purl.obolibrary.org/obo/ERO_0000923,phenotype characterization,"An organismal assay that involves characterization of a phenotype; any observable characteristic or trait of an organism: such as its morphology, development, biochemical or physiological properties, behavior, and products of behavior (such as a bird's nest). Phenotypes result from the expression of an organism's genes as well as the influence of environmental factors and the interactions between the two.",None
http://purl.obolibrary.org/obo/CHEBI_25970,phenoxazine,None,None
http://purl.obolibrary.org/obo/CHEBI_36357,polyatomic entity,Any molecular entity consisting of more than one atom.,None
http://purl.obolibrary.org/obo/CHEBI_15986,polynucleotide,A nucleobase-containing molecular entity with a polymeric structure comprised of a linear sequence of 13 or more nucleotide residues.,None
http://purl.obolibrary.org/obo/GO_0048518,positive regulation of biological process,"Any process that activates or increases the frequency, rate or extent of a biological process. Biological processes are regulated by many means; examples include the control of gene expression, protein modification or interaction with a protein or substrate molecule.",None
http://purl.obolibrary.org/obo/CHEBI_36080,protein,A biological macromolecule minimally consisting of one polypeptide chain synthesized at the ribosome.,None
http://purl.obolibrary.org/obo/GO_0043234,protein complex,A stable macromolecular complex composed (only) of two or more polypeptide subunits along with any covalently attached molecules (such as lipid anchors or oligosaccharide) or non-protein prosthetic groups (such as nucleotides or metal ions). Prosthetic group in this context refers to a tightly bound cofactor. The component polypeptide subunits may be identical.,None
http://purl.obolibrary.org/obo/CHEBI_60911,racemate,A racemate is an equimolar mixture of a pair of enantiomers.,None
http://purl.obolibrary.org/obo/UO_0000190,ratio,A dimensionless unit which denotes an amount or magnitude of one quantity relative to another.,None
http://purl.obolibrary.org/obo/GO_0050789,regulation of biological process,"Any process that modulates the frequency, rate or extent of a biological process. Biological processes are regulated by many means; examples include the control of gene expression, protein modification or interaction with a protein or substrate molecule.",None
http://purl.obolibrary.org/obo/GO_0032879,regulation of localization,"Any process that modulates the frequency, rate or extent of any process in which a cell, a substance, or a cellular entity is transported to, or maintained in, a specific location.",None
http://purl.obolibrary.org/obo/GO_0051049,regulation of transport,"Any process that modulates the frequency, rate or extent of the directed movement of substances (such as macromolecules, small molecules, ions) into, out of or within a cell, or between cells, by means of some agent such as a transporter or pore.",None
http://purl.obolibrary.org/obo/GO_0032409,regulation of transporter activity,Any process that modulates the activity of a transporter.,None
http://purl.obolibrary.org/obo/CHEBI_51602,resorufin,None,None
http://purl.obolibrary.org/obo/CHEBI_33697,ribonucleic acid,"High molecular weight, linear polymers, composed of nucleotides containing ribose and linked by phosphodiester bonds; RNA is central to the synthesis of proteins.",None
http://purl.obolibrary.org/obo/CHEBI_38545,rosuvastatin,"A dihydroxy monocarboxylic acid that is (6E)-7-{4-(4-fluorophenyl)-2-[methyl(methylsulfonyl)amino]-6-(propan-2-yl)pyrimidin-5-yl} hept-6-enoic acid carrying two hydroxy substituents at positions 3 and 5 (the 3R,5S-diastereomer).",None
http://purl.obolibrary.org/obo/OAE_0000631,severe adverse event,"serious adverse event is an adverse event that requires in-patient hospitalization, or prolongation of existing hospitalization, or that causes congenital malformation, or that results in persistent or significant disability or incapacity, or that is life threatening or results in death.",None
http://purl.obolibrary.org/obo/ERO_0001209,siRNA oligonucleotide,"An RNA interference oligonucleotide capable of silencing expression of a target gene through the RNAi pathway.  siRNAs are synthesized as single-stranded molecules, typically 19-25 nucleotides in length, and paired with complementary sequences to form duplexes that serve as substrates for cellular RNAi processing machinery.",siRNA oligo
http://purl.obolibrary.org/obo/CHEBI_9150,simvastatin,"A fatty acid ester comprising a dihydroxyheptanoic acid unit condensed into a lactone; a partially reduced naphthalene structure; and a 2,2-dimethylbutyric acyl substituent at C17. It is used as a cholesterol-lowering and anti-cardiovascular disease drug.",None
http://purl.obolibrary.org/obo/PR_000015223,solute carrier organic anion transporter family member 1B1,A solute carrier organic anion transporter family member that is a translation product of the human SLCO1B1 gene or a 1:1 ortholog thereof.,None
http://purl.obolibrary.org/obo/PR_000015224,solute carrier organic anion transporter family member 1B3,A solute carrier organic anion transporter family member that is a translation product of the human SLCO1B3 gene or a 1:1 ortholog thereof.,None
http://purl.obolibrary.org/obo/OBI_0000659,specimen collection process,A planned process with the objective of collecting a specimen.,specimen collection
http://purl.obolibrary.org/obo/GO_0006810,transport,"The directed movement of substances (such as macromolecules, small molecules, ions) or cellular components (such as complexes and organelles) into, out of or within a cell, or between cells, or within a multicellular organism by means of some agent such as a transporter, pore or motor protein.",None
http://purl.obolibrary.org/obo/OGMS_0000090,treatment,A processual entity whose completion is hypothesized (by a healthcare provider) to alleviate the signs and symptoms associated with a disorder,None
http://purl.obolibrary.org/obo/CHEBI_9674,triazolam,A triazolobenzodiazepine that has formula C17H12Cl2N4.,None
http://purl.obolibrary.org/obo/CHEBI_38597,triazole,None,None
http://purl.obolibrary.org/obo/CHEBI_35501,triazolobenzodiazepine,None,None
http://purl.obolibrary.org/obo/UO_0000000,unit,A unit of measurement is a standardized quantity of a physical quality.,None
http://purl.obolibrary.org/obo/OBI_0001933,value specification,An information content entity that specifies a value within a classification scheme or on a quantitative scale.,None
http://purl.obolibrary.org/obo/DIDEO_00000189,293 transfected cell,a 293-derived cell that is a specified output of a transfection,HEK293 transfected cell
http://purl.obolibrary.org/obo/CLO_0037237,293-derived cell,None,293 HEK
http://purl.obolibrary.org/obo/CLO_0037237,293-derived cell,None,293
http://purl.obolibrary.org/obo/CLO_0037237,293-derived cell,None,HEK-293
http://purl.obolibrary.org/obo/CLO_0037237,293-derived cell,None,HEK 293
http://purl.obolibrary.org/obo/CLO_0037237,293-derived cell,None,HEK293
http://purl.obolibrary.org/obo/DIDEO_00000172,7-ethoxyresorufin O-deethylation,a deethylation that has 7-ethoxyresorufin as input and resorufin as output,None
http://purl.obolibrary.org/obo/DIDEO_00000186,CHO transfected cell,a CHO cell that is a specified output of a transfection,None
http://purl.obolibrary.org/obo/DIDEO_00000169,E. coli recombinant protein production host cell,a cultured cell of the species Escherichia coli that has a recombinant protein production host role,None
http://purl.obolibrary.org/obo/DIDEO_00000158,Fa2N-4 cell,an immortal human liver-derived cell line cell that is part of the Fa2N-4 cell line,None
http://purl.obolibrary.org/obo/DIDEO_00000159,HBG BC2 cell,an immortal human liver-derived cell line cell that is part of the HBG BC2 cell line,BC2 cell
http://purl.obolibrary.org/obo/DIDEO_00000185,Hep G2 cell,an immortal human liver-derived cell line cell that is part of the Hep G2 cell line,None
http://purl.obolibrary.org/obo/DIDEO_00000187,Hep G2 transfected cell,a Hep G2 cell that has a target of material addition role and is a specified input of a transfection,None
http://purl.obolibrary.org/obo/DIDEO_00000157,HepaRG cell,an immortal human liver-derived cell line cell that is part of the HepaRG cell line,None
http://purl.obolibrary.org/obo/DIDEO_00000045,U.S. Food and Drug Administration drug label,None,FDA drug label
http://purl.obolibrary.org/obo/DIDEO_00000034,absorbability,None,None
http://purl.obolibrary.org/obo/DIDEO_00000036,absorbability measurement datum,A a scalar measurement datum that is the specified outcome of an drug absorbability assay.,AUC
http://purl.obolibrary.org/obo/DRON_00000028,active ingredient,a role of a scattered molecular aggregate that is part of a drug product that is realized by (1) administration of the drug to an organism followed by (2) some change in the structure or functioning of some part of the organism,None
http://purl.obolibrary.org/obo/OAE_0000005,adverse drug event,an adverse event that occurs after a drug administration,None
http://purl.obolibrary.org/obo/DIDEO_00000087,adverse drug reaction causality evaluation protocol,None,None
http://purl.obolibrary.org/obo/OAE_0000001,adverse event,"a pathological bodily process that occurs after a medical intervention. An adverse event is likely caused by the medical intervention; however, such a causal association is not required to be an adverse event.",None
http://purl.obolibrary.org/obo/STATO_0000209,area under curve,Area under curve is a measurement datum which corresponds to the surface define by the x-axis and bound by the line graph represented in a 2 dimensional plot resulting from an integration or integrative calculus. The interpretation of this measurement datum depends on the variables plotted in the graph,None
http://purl.obolibrary.org/obo/DIDEO_00000093,area under the curve ratio,None,AUC ratio
http://purl.obolibrary.org/obo/OBI_0000070,assay,"A planned process with the objective to produce information about the material entity that is the evaluant, by physically examining it or its proxies.",measuring
http://purl.obolibrary.org/obo/OBI_0000070,assay,"A planned process with the objective to produce information about the material entity that is the evaluant, by physically examining it or its proxies.",scientific observation
http://purl.obolibrary.org/obo/DIDEO_00000168,baculovirus-insect recombinant protein production host cell,a cultured cell that is part of a culture derived from an insect and has a recombinant protein production host role,baculovirus-insect cell
http://purl.obolibrary.org/obo/DIDEO_00000010,bioavailability,Bioavailability is a disposition that is borne by a drug product and is realized by the process of a proportion of the active pharmaceutical ingredient in that drug product reaching systemic circulation.,None
http://purl.obolibrary.org/obo/DIDEO_00000025,bioavailability measurement datum,A scalar measurement datum that is the specified outcome of a drug bioavailability assay.,F
http://purl.obolibrary.org/obo/DIDEO_00000102,bioavailability ratio,"A pharmacokinetic parameter ratio that describes the relation between the measurement of the fraction of the administered dose of an unaltered drug that reaches systemic circulation in the abscene of another drug, and the the measurement of the fraction of the administered dose of an unaltered drug that reaches systemic circulation when coadministered with another drug.",F ratio
http://purl.obolibrary.org/obo/DIDEO_00000174,bufuralol 1'-hydroxylation,a hydroxylation that has bufuralol as input and 1'-hydroxybufurolol as output,None
http://purl.obolibrary.org/obo/DIDEO_00000176,bupropion hydroxylation,a hydroxylation that has bupropion as input and 1-hydroxybuproprion as output,None
http://purl.org/obo/owl/GO#GO_0003824,catalytic activity,None,None
http://purl.obolibrary.org/obo/OAE_0000095,causal adverse drug event,a drug adverse event that is caused by a drug adiministration. Here a causal effect is established between the drug administration and the adverse event.,None
http://purl.obolibrary.org/obo/CLO_0000031,cell line,A cultured cell population that represents a genetically stable and homogenous population of cultured cells that shares a common propagation history (i.e. has been successively passaged together in culture).,None
http://purl.obolibrary.org/obo/OBI_1000024,cell pellet,A material entity which results from the aggregation of cells produced by the application of centrifugal force to a liquid containing cells in suspension,None
http://purl.org/obo/owl/GO#GO_0009987,cellular process,None,None
http://purl.obolibrary.org/obo/OBI_0302886,centrifugation,centrifugation is a process separating molecules by size or density using centrifugal forces generated by a spinning rotor. G-forces of several hundred thousand times gravity are generated in ultracentrifugation,None
http://purl.obolibrary.org/obo/OBI_0000029,centrifuge pellet role,pellet role is a role which inheres in a material entity and is realized by a material separation process using gravitational force generated by a centrifuge in which the material bearing the pellet role is the heavier or heaviest component of the output material..,None
http://purl.obolibrary.org/obo/CHEBI_24431,chemical entity,None,None
http://purl.obolibrary.org/obo/DIDEO_00000089,clearance measurement datum,None,Cl
http://purl.obolibrary.org/obo/OBI_0500001,clinical study design,"Plan for the precise procedure to be followed in a clinical trial, including planned and actual timing of events, choice of control group, method of allocating treatments, blinding methods; assigns a subject to pass through one or more epochs in the course of a trial. Specific design elements, e.g., crossover, parallel; dose-escalation [Modified from Pocock, Clinical Trials: A Practical Approach]",None
http://purl.obolibrary.org/obo/DIDEO_00000024,clinically relevant potential drug-drug interaction,A potential drug-drug interaction that is causally linked to an elevated risk of an adverse event that warrants a drug-drug interaction management option.,None
http://purl.obolibrary.org/obo/OAE_0000055,contraindication,"A contraindication is a disposition that increases the risk of harm involved in using a particular drug, carrying out a medical procedure, or engaging in a particular activity such that the risk of harm exceeds a threshold. An contraindication serves as a reason to withhold a certain medical treatment.",None
http://purl.obolibrary.org/obo/DIDEO_00000179,coumarin 7-hydroxylation,a hydroxylation that has coumarin as input and has 7-hydroxycoumarin as output,None
http://purl.obolibrary.org/obo/APOLLO_SV_00000032,count,A measurement datum that is the output of counting.,None
http://purl.obolibrary.org/obo/DIDEO_00000149,cryopreserved human hepatocyte population,a cultured cell population that is derived from hepatocytes isolated from a human being and that has undergone cryopreservation,None
http://purl.obolibrary.org/obo/DIDEO_00000002,data item about biological process,None,mechanistic assertion data item
http://purl.obolibrary.org/obo/DIDEO_00000005,data item from extrapolation,"A data item that is the output of a process of estimating, beyond the original observation range, the value of a variable on the basis of its relationship with another variable.",None
http://purl.obolibrary.org/obo/DIDEO_00000181,dextromethorphan O-demethylation,a demethylation that has dextromethorphan as input and has dextrorphan as output,None
http://purl.obolibrary.org/obo/DIDEO_00000182,diclofenac 4'-hydroxylation,a hydroxylation that has diclofenac as input and 4'-hydroxydiclofenac as output,None
http://purl.obolibrary.org/obo/DIDEO_00000191,diclofenac 4'-hydroxylation,a hydroxylation that has diclofenac as input and 4'-hydroxydiclofenac as output,None
http://purl.obolibrary.org/obo/DIDEO_00000035,drug absorbability assay,An assay with the objective to capture information about the absorbability of an active ingredient in a drug product.,None
http://purl.obolibrary.org/obo/DRON_00000031,drug administration,a treatment that has as participants an extended organism and a drug product and that results in part of the drug product being located in the extended organism,None
http://purl.obolibrary.org/obo/DIDEO_00000026,drug bioavailability assay,An assay with the objective to capture information about the bioavailability of an active ingredient in a drug product.,None
http://purl.obolibrary.org/obo/DIDEO_00000021,drug co-administration,A planned process of administering more than one drug to the same individual over a specific time interval.,None
http://purl.obolibrary.org/obo/DIDEO_00000032,drug first pass metabolism assay,None,None
http://purl.obolibrary.org/obo/DIDEO_00000037,drug maximum concentration assay,None,None
http://purl.obolibrary.org/obo/DIDEO_00000038,drug maximum concentration measurement datum,A scalar measurement datum that is the specified outcome of a drug maximum concentration assay.,Cmax
http://purl.obolibrary.org/obo/DIDEO_00000099,drug maximum concentration ratio,A pharmacokinetic parameter ratio that describes the relation between the drug maximum concentration measurements for a given active ingredient or metabolite in an organism with and without the inhibiting drug present in the organism.,Cmax ratio
http://purl.org/obo/owl/GO#GO_0017144,drug metabolic process,None,None
http://purl.obolibrary.org/obo/DIDEO_00000047,drug package AUC information,An information content entity that is part of a drug package insert and that is about a pharmacokinetic area under the curve measurement result.,None
http://purl.obolibrary.org/obo/DIDEO_00000044,drug package insert,A document that is provided along with a medication and that gives additional information about that medication.,None
http://purl.obolibrary.org/obo/DRON_00000005,drug product,a material entity (1) containing at least one scattered molecular aggregate as part (the active ingredient) and (2) that is the bearer of a clinical drug role,None
http://purl.obolibrary.org/obo/DIDEO_00000020,drug-drug interaction,A biological process that results in a clinically meaningful change to the response of at least one co-administrated drug.,DDI
http://purl.obolibrary.org/obo/DIDEO_00000001,drug-drug interaction description,An information content entity that is about a drug-drug interaction.,DDI description
http://purl.obolibrary.org/obo/DIDEO_00000043,drug-drug interaction description from FDA label information,None,None
http://purl.obolibrary.org/obo/DIDEO_00000042,drug-drug interaction description from drug package insert,None,None
http://purl.obolibrary.org/obo/DIDEO_00000030,drug-drug interaction effect,An entity that is the result of a drug-drug interaction.,None
http://purl.obolibrary.org/obo/DIDEO_00000023,drug-drug interaction evidence,An information content entity that is about a drug co-administration and is intended to be specified input into the assessment of whether a drug-drug interaction exists or not.,None
http://purl.obolibrary.org/obo/DIDEO_00000007,drug-drug interaction management option,A evidence-based plan specification that specifies processes to prevent or mitigate a drug-drug interaction,management option
http://purl.obolibrary.org/obo/DIDEO_00000120,efflux ratio,None,None
http://purl.obolibrary.org/obo/OBI_0000427,enzyme,"(protein or rna) or has_part (protein or rna) and
has_function some GO:0003824 (catalytic activity)",None
http://purl.obolibrary.org/obo/OBI_0000067,evaluant role,a role that inheres in a material entity that is realized in an assay in which data is generated about the bearer of the evaluant role,None
http://purl.obolibrary.org/obo/DIDEO_00000055,evidence data item,None,None
http://purl.obolibrary.org/obo/DIDEO_00000053,evidence information content entity,An information content entity that is used to support or refute an assertion.,None
http://purl.obolibrary.org/obo/DIDEO_00000063,evidence information from CYP450 drug metabolism identification experiment,"An evidence information content entity that is about an in vitro assay that has a part of a drug or a drug metabolite, which participate in a metabolic process that has CYP 450 as a participant, as a specified input.",EV_EX_Met_Enz_ID_Cyp450
http://purl.obolibrary.org/obo/DIDEO_00000067,evidence information from CYP450 human microsome drug metabolism identification experiment,"An evidence information content entity that is about an in vitro assay that has a part of a drug or a drug metabolite, which participate in a metabolic process that has CYP 450 as a participant, as a specified input, and that has human tissue specimen as a specified input.",EV_EX_Met_Enz_ID_Cyp450_Hum_Microsome
http://purl.obolibrary.org/obo/DIDEO_00000069,evidence information from CYP450 human microsome drug metabolism identification experiment using antibody inhibitors,"An evidence information content entity that is about an in vitro assay that has a part of a drug or a drug metabolite, which participate in a metabolic process that has CYP 450 as a participant, as a specified input, and that has human tissue specimen as a specified input, and that has antibody inhibitors as a specified input.",EV_EX_Met_Enz_ID_Cyp450_Hum_Microsome_Antibody
http://purl.obolibrary.org/obo/DIDEO_00000068,evidence information from CYP450 human microsome drug metabolism identification experiment using chemical inhibitors,"An evidence information content entity that is about an in vitro assay that has a part of a drug or a drug metabolite, which participate in a metabolic process that has CYP 450 as a participant, as a specified input, and that has human tissue specimen as a specified input, and that has chemical inhibitors as a specified input.",EV_EX_Met_Enz_ID_Cyp450_Hum_Microsome_Chem
http://purl.obolibrary.org/obo/DIDEO_00000081,evidence information from CYP450 human microsome drug metabolism inhibition experiment,"An evidence information content entity that is about an in vitro assay and that has parts of a drug or drug metabolites, which participate in a negative regulation of a metabolic process that also involves CYP 450, as it's specified input, and that has human tissue specimens as a specified input.",EV_EX_Met_Enz_Inhibit_Cyp450_Hum_Microsome
http://purl.obolibrary.org/obo/DIDEO_00000070,evidence information from CYP450 metabolic enzyme inhibition experiment,"An evidence information content entity that is about an in vitro assay and that has parts of a drug or drug metabolites, which participate in a negative regulation of a metabolic process that also involves CYP 450, as it's specified input.",EV_EX_Met_Enz_Inhibit_Cyp450
http://purl.obolibrary.org/obo/DIDEO_00000064,evidence information from CYP450 recombinant drug metabolism identification experiment,"An evidence information content entity that is about an in vitro assay that has a part of a drug or a drug metabolite, which participate in a metabolic process that has CYP 450 as a participant, as a specified input, and that has a cell line as a specified input.",EV_EX_Enz_ID_Cyp450_Hum_Recom
http://purl.obolibrary.org/obo/DIDEO_00000066,evidence information from CYP450 recombinant drug metabolism identification experiment using antibody inhibitors,"An evidence information content entity that is about an in vitro assay that has a part of a drug or a drug metabolite, which participate in a metabolic process that has CYP 450 as a participant, as a specified input, and that has human tissue specimen as a specified input, and that has antibody inhibitors as a specified input.",EV_EX_Met_Enz_ID_Cyp450_Hum_Recom_Antibody
http://purl.obolibrary.org/obo/DIDEO_00000065,evidence information from CYP450 recombinant drug metabolism identification experiment using chemical inhibitors,"An evidence information content entity that is about an in vitro assay that has a part of a drug or a drug metabolite, which participate in a metabolic process that has CYP 450 as a participant, as a specified input, and that has human tissue specimen as a specified input, and that has chemical inhibitors as a specified input.",EV_EX_Met_Enz_ID_Cyp450_Hum_Recom_Chem
http://purl.obolibrary.org/obo/DIDEO_00000080,evidence information from CYP450 recombinant drug metabolism inhibition experiment,"An evidence information content entity that is about an in vitro assay and that has parts of a drug or drug metabolites, which participate in a negative regulation of a metabolic process that also involves CYP 450, as it's specified input, and that has cell lines as a specified input.",EV_EX_Met_Enz_Inhibit_Cyp450_Hum_Recom
http://purl.obolibrary.org/obo/DIDEO_00000114,evidence information from OATP1B1 inhibition experiment,"An evidence information content entity that is about an assay that realizes an ex vivo design, and that has chemical substances as its specific input, which are the outcome of the inhibition of OATP1B1.",EV_EX_Trans_Prot_Inhibit_OATP1B1
http://purl.obolibrary.org/obo/DIDEO_00000115,evidence information from OATP1B1 inhibition experiment using overexpressed cell lines,"An evidence information content entity that is about an assay that realizes an ex vivo design, and that has chemical substances as its specific input, which are the outcome of the inhibition of OATP1B1, and that has overexpressed cell lines as a specified input.",EV_EX_Trans_Prot_Inhibit_OATP1B1_Overexpressed_Cells
http://purl.obolibrary.org/obo/DIDEO_00000107,evidence information from OATP1B1 transport protein identification experiment,"An evidence information content entity that is about an assay that realizes an ex vivo design, and that has chemical substances as its specific input, which are the outcome of drug components being imported across plasma membranes by involvement of OATP1B1.",EV_EX_Trans_Prot_ID_OATP1B1
http://purl.obolibrary.org/obo/DIDEO_00000109,evidence information from OATP1B1 transport protein identification experiment using overexpressed cell lines,"An evidence information content entity that is about an assay that realizes an ex vivo design, and that has chemical substances as its specific input, which are the outcome of drug components being imported across plasma membranes by involvement of OATP1B1 using overexpressed cells.",EV_EX_Trans_Prot_ID_OATP1B1_Overexpressed_Cells
http://purl.obolibrary.org/obo/DIDEO_00000117,evidence information from OATP1B3 inhibition experiment,"An evidence information content entity that is about an assay that realizes an ex vivo design, and that has chemical substances as its specific input, which are the outcome of the inhibition of OATP1B3.",EV_EX_Trans_Prot_Inhibit_OATP1B3
http://purl.obolibrary.org/obo/DIDEO_00000116,evidence information from OATP1B3 inhibition experiment using overexpressed cell lines,"An evidence information content entity that is about an assay that realizes an ex vivo design, and that has chemical substances as its specific input, which are the outcome of the inhibition of OATP1B3, and that has overexpressed cell lines as a specified input.",EV_EX_Trans_Prot_Inhibit_OATP1B3_Overexpressed_Cells
http://purl.obolibrary.org/obo/DIDEO_00000108,evidence information from OATP1B3 transport protein identification experiment,"An evidence information content entity that is about an assay that realizes an ex vivo design, and that has chemical substances as its specific input, which are the outcome of drug components being imported across plasma membranes by involvement of OATP1B3.",EV_EX_Trans_Prot_ID_OATP1B3
http://purl.obolibrary.org/obo/DIDEO_00000110,evidence information from OATP1B3 transport protein identification experiment using overexpressed cell lines,"An evidence information content entity that is about an assay that realizes an ex vivo design, and that has chemical substances as its specific input, which are the outcome of drug components being imported across plasma membranes by involvement of OATP1B3 using overexpressed cells.",EV_EX_Trans_Prot_ID_OATP1B3_Overexpressed_Cells
http://purl.obolibrary.org/obo/DIDEO_00000083,evidence information from a publicly reported observation-based adverse drug event report,"An evidence information content entity that is about an assay that was triggered by an adverse drug event, and that is part on a publicly accessible database for adverse event reporting.",EV_Case_Report_ADE_Public_Reported
http://purl.obolibrary.org/obo/DIDEO_00000088,evidence information from an evaluated observation-based case-report of a drug interaction,"An evidence information content entity that is about an assay that was triggered by an adverse drug event following the administration of at least two drugs, and that is the specified outcome of a adverse drug reaction causality evaluation.",EV_Case_Report_DI_Evaluated
http://purl.obolibrary.org/obo/DIDEO_00000084,evidence information from an observation-based case-report of a drug interaction,An evidence information content entity that is about an assay that was triggered by an adverse drug event following the administration of at least two drugs.,EV_Case_Report_DI
http://purl.obolibrary.org/obo/DIDEO_00000056,evidence information from clinical study,An evidence information content entity that is about a clinical drug trial.,EV_Clinical_Trial
http://purl.obolibrary.org/obo/DIDEO_00000057,evidence information from drug metabolism identification experiment,"An evidence information content entity that is about an in vitro assay that has a part of a drug or a drug metabolite, which participate in a metabolic process, as a specified input.",EV_EX_Met_Enz_ID
http://purl.obolibrary.org/obo/DIDEO_00000058,evidence information from drug metabolism inhibition experiment,"An evidence information content entity that is about an in vitro assay and that has parts of a drug or drug metabolites, which participate in a negative regulation of a metabolic process, as it's specified input.",EV_EX_Met_Enz_Inhibit
http://purl.obolibrary.org/obo/DIDEO_00000071,evidence information from drug-drug interaction clinical trial,An evidence information content entity that is about a clinical drug trial that has at least two drugs as its specified input.,EV_CT_DDI
http://purl.obolibrary.org/obo/DIDEO_00000076,evidence information from genotyped pharmacokinetic trial,An evidence information content entity that is about a clinical drug trial that focusses on pharmacokinetics and that has organisms as participants that participated in genotyping.,EV_CT_PK_Genotype
http://purl.obolibrary.org/obo/DIDEO_00000072,evidence information from non-randomized drug-drug interaction clinical trial,An evidence information content entity that is about a clinical drug trial that has at least two drugs as its specified input and does not have group randomization as a part.,EV_PK_DDI_NR
http://purl.obolibrary.org/obo/DIDEO_00000061,evidence information from observation-based adverse drug event report,An evidence information content entity that is about an assay that was triggered by an adverse drug event.,EV_Case_Report_ADE
http://purl.obolibrary.org/obo/DIDEO_00000077,evidence information from observation-based report,An evidence information content entity that is about an assay that was triggered by an occurrent.,EV_Case_Report
http://purl.obolibrary.org/obo/DIDEO_00000079,evidence information from observational drug-drug interaction study,"An evidence information content entity that is about an assay that realizes an observation design and has at least two drug products as a specified input, and that focuses on pharmacokinetics in an organism.",EV_PK_DDI_Observational
http://purl.obolibrary.org/obo/DIDEO_00000078,evidence information from observational pharmacokinetic study,"An evidence information content entity that is about an assay that realizes an observation design and has a drug product as a specified input, and that focuses on pharmacokinetics in an organism.",EV_PK_Observational
http://purl.obolibrary.org/obo/DIDEO_00000062,evidence information from observational study,An evidence information content entity that is about an assay that realizes an observation design.,EV_Observational
http://purl.obolibrary.org/obo/DIDEO_00000111,evidence information from p-glycoprotein inhibition experiment,"An evidence information content entity that is about an assay that realizes an ex vivo design, and that has chemical substances as its specific input, which are the outcome of the inhibition of P-Glycoprotein.",EV_EX_Trans_Prot_Inhibit_P_Glycoprotein
http://purl.obolibrary.org/obo/DIDEO_00000112,evidence information from p-glycoprotein inhibition experiment using Caco 2 cell lines,"An evidence information content entity that is about an assay that realizes an ex vivo design, and that has chemical substances as its specific input, which are the outcome of the inhibition of P-Glycoprotein, and that has Caco 2 cell lines as a specified input.",EV_EX_Trans_Prot_Inhibit_P_Glycoprotein_Caco_2
http://purl.obolibrary.org/obo/DIDEO_00000113,evidence information from p-glycoprotein inhibition experiment using overexpressed cell lines,"An evidence information content entity that is about an assay that realizes an ex vivo design, and that has chemical substances as its specific input, which are the outcome of the inhibition of P-Glycoprotein, and that has overexpressed cell lines as a specified input.",EV_EX_Trans_Prot_Inhibit_P_Glycoprotein_Overexpressed_Cells
http://purl.obolibrary.org/obo/DIDEO_00000104,evidence information from p-glycoprotein transport protein identification experiment,"An evidence information content entity that is about an assay that realizes an ex vivo design, and that has chemical substances as its specific input, which are the outcome of drug components being imported across plasma membranes by involvement of P-Glycoprotein.",EV_EX_Trans_Prot_ID_P_Glycoprotein
http://purl.obolibrary.org/obo/DIDEO_00000105,evidence information from p-glycoprotein transport protein identification experiment using Caco 2 cell lines,"An evidence information content entity that is about an assay that realizes an ex vivo design, and that has chemical substances as its specific input, which are the outcome of drug components being imported across plasma membranes by involvement of P-Glycoprotein using bidirectional flux in Caco-2 cells.",EV_EX_Trans_Prot_ID_P_Glycoprotein_Caco_2
http://purl.obolibrary.org/obo/DIDEO_00000106,evidence information from p-glycoprotein transport protein identification experiment using overexpressed cell lines,"An evidence information content entity that is about an assay that realizes an ex vivo design, and that has chemical substances as its specific input, which are the outcome of drug components being imported across plasma membranes by involvement of P-Glycoprotein using overexpressed cells.",EV_EX_Trans_Prot_ID_P_Glycoprotein_Overexpressed_Cells
http://purl.obolibrary.org/obo/DIDEO_00000073,evidence information from parallel groups drug-drug interaction clinical trial',"An evidence information content entity that is about a clinical drug trial that has at least two drugs as its specified input, and that does not have group randomization as a part, and that realizes a clinical study design that has parallel group design as a part.",EV_PK_DDI_Par_Grps
http://purl.obolibrary.org/obo/DIDEO_00000075,evidence information from pharmacokinetic trial,An evidence information content entity that is about a clinical drug trial that focusses on pharmacokinetics.,EV_CT_Pharmacokinetic
http://purl.obolibrary.org/obo/DIDEO_00000075,evidence information from pharmacokinetic trial,,EV_CT_Pharmacokinetic
http://purl.obolibrary.org/obo/DIDEO_00000103,evidence information from phenotyped pharmacokinetic trial,An evidence information content entity that is about a clinical drug trial that focusses on pharmacokinetics and that has organisms as participants that participated in phenotyping.,EV_CT_PK_Phenotype
http://purl.obolibrary.org/obo/DIDEO_00000074,evidence information from randomized drug-drug interaction clinical trial,An evidence information content entity that is about a clinical drug trial that has at least two drugs as its specified input and does have group randomization as a part.,EV_PK_DDI_RCT
http://purl.obolibrary.org/obo/DIDEO_00000059,evidence information from transport protein identification experiment,"An evidence information content entity that is about an assay that realizes an ex vivo design, and that has chemical substances as its specific input, which are the outcome of drug components being imported across plasma membranes.",EV_EX_Trans_Prot_ID
http://purl.obolibrary.org/obo/DIDEO_00000060,evidence information from transport protein inhibition experiment,"An evidence information content entity that is about an assay that realizes an ex vivo design, and that has chemical substances as its specific input, which are the outcome of the inhibition of drug component transporter.",EV_EX_Trans_Prot_Inhibit
http://purl.obolibrary.org/obo/DIDEO_00000054,evidence material information,An information content entity that is part of an evidence information content entity and mentions the specified input to an assay.,None
http://purl.obolibrary.org/obo/OBI_0001211,ex vivo design,"A study design where all or part of an organism is removed and studied in vitro, e.g. part of a mouse is removed and cultured in vitro. A cell culture with an established cell line is an in vitro experiment.",None
http://purl.obolibrary.org/obo/DIDEO_00000031,first pass effect disposition,None,None
http://purl.obolibrary.org/obo/DIDEO_00000033,first pass metabolism measurement datum,None,None
http://purl.obolibrary.org/obo/DIDEO_00000091,fold,None,None
http://purl.obolibrary.org/obo/DIDEO_00000152,freshly isolated human hepatocyte population,a cultured cell population that is derived from hepatocytes isolated from a human being and that has not been frozen,None
http://purl.obolibrary.org/obo/DIDEO_00000006,gastrointestinal functioning,"A biological process that realizes the function of the gastrointestinal system (or any organ that is a part of it.). This includes digestion of ingested substances, absorption and eliminating waste.",None
http://purl.obolibrary.org/obo/OBI_0001148,gene knock out,"a genetic transformation that renders a gene non-functional, e.g. due to a point mutation, or the removal of all, or part of, the gene using recombinant methods.",None
http://purl.obolibrary.org/obo/OBI_0600043,genetic transformation,the introduction. alteration or integration of genetic material into a cell or organism,genetic modification
http://purl.obolibrary.org/obo/OBI_0600015,group assignment,group assignment is a process which has an organism as specified input and during which a role is assigned,cohort assignment
http://purl.obolibrary.org/obo/OBI_0600015,group assignment,group assignment is a process which has an organism as specified input and during which a role is assigned,study assignment
http://purl.obolibrary.org/obo/OBI_0302900,group randomization,A group assignment which relies on chance to assign materials to a group of materials in order to avoid bias in experimental set up.,None
http://purl.obolibrary.org/obo/DIDEO_00000100,half-life ratio,A pharmacokinetic parameter ratio that describes the relation between the time it takes for half of a given active ingredient or metabolite to be removed from the system of an organism with and without the inhibiting drug present in the organism.,t1/2 ratio
http://purl.obolibrary.org/obo/DIDEO_00000101,hepatic clearance ratio,"A pharmacokinetic parameter ratio that describes the relation between the measurement of the volume of blood, serum, or plasma from which an active ingredient or a metabolite is completely removed by the liver in a given amount of time in an organism with and without the inhibiting drug present in the organism.",CL_H ratio
http://purl.obolibrary.org/obo/DIDEO_00000155,human intestinal epithelial cell population,a cultured cell population derived from cells isolated from human intestinal epithelium,None
http://purl.obolibrary.org/obo/DIDEO_00000167,human intestine S9 fraction,"a processed material that has a supernatant role resulting from centrifugation of a homogeneous mixture of human enterocytes at 12,000 g",None
http://purl.obolibrary.org/obo/DIDEO_00000161,human intestine cytosolic fraction,"a processed material that has a supernatant role resulting from centrifugation of a human intestine S9 fraction at 104,000 g",None
http://purl.obolibrary.org/obo/DIDEO_00000162,human liver S9 fraction,"a processed material that has a supernatant role resulting from centrifugation of a homogeneous mixture of human liver cells at 12,000 g",None
http://purl.obolibrary.org/obo/DIDEO_00000160,human liver cytosolic fraction,"a processed material that has a supernatant role resulting from centrifugation of a human intestine S9 fraction at 104,000 g",None
http://purl.obolibrary.org/obo/OBI_0001285,in vitro design,"A study design that is done in a test tube or a culture dish, e.g. A bacterial invasion assay in an established cell culture.",None
http://purl.obolibrary.org/obo/DIDEO_00000163,individual human intestinal microsomal fraction,"a processed material that has a centrifuge pellet role resulting from centrifugation of a human liver S9 fraction, which is derived from a single donor, at 104,000 g",individual human intestinal microsomes
http://purl.obolibrary.org/obo/DIDEO_00000165,individual human liver microsomal fraction,"a processed material that has a centrifuge pellet role resulting from centrifugation at 104,000 g of a human liver S9 fraction, which is derived from a single donor",individual human liver microsomes
http://purl.obolibrary.org/obo/DIDEO_00000051,information about decrease of pharmacokinetic area under the curve,A pharmacokinetic area under curve information that is about at least 2 area under curve measurments and the time series shows a decrease of the area under curve.,None
http://purl.obolibrary.org/obo/DIDEO_00000050,information about increase of pharmacokinetic area under the curve,A pharmacokinetic area under curve information that is about at least 2 area under curve measurments and the time series shows an increase of the area under curve.,None
http://purl.obolibrary.org/obo/DIDEO_00000122,inhibitory constant,None,ki
http://purl.obolibrary.org/obo/OBI_0600014,material component separation,a material processing in which components of an input material become segregated in space,None
http://purl.obolibrary.org/obo/DIDEO_00000019,material entity participant in drug-drug interaction,A drug product or drug ingredient that participates in a drug-drug interaction.,Drug participant in drug-drug interaction
http://purl.obolibrary.org/obo/OBI_0000094,material processing,A planned process which results in physical changes in a specified input material,material transformation
http://purl.obolibrary.org/obo/DIDEO_00000022,mechanism of interaction information,An information content entity that represents a drug interaction as a directional series of molecular processes.,drug interaction mechanism
http://purl.obolibrary.org/obo/DIDEO_00000015,metabolic potential drug-drug interaction,A potential drug drug interaction that is about a drug metabolism.,None
http://purl.obolibrary.org/obo/DIDEO_00000018,metabolism induction potential drug-drug interaction,A metabolism induction potential drug-drug interaction that is about an increase of an enzyme participating in the metabolic process.,None
http://purl.obolibrary.org/obo/DIDEO_00000017,metabolism inhibition potential drug-drug interaction,A metabolism induction potential drug-drug interaction that is about an decrease of metabolic activity  because of either a decreased expression of the enzyme or inference with how the enzyme contributes to the metabolic process.,None
http://purl.obolibrary.org/obo/OBI_0000192,microtiter plate,A microtiter_plate is a flat plate with multiple wells used as small test tubes.,microplate
http://purl.obolibrary.org/obo/DIDEO_00000171,midazolam 1'-hydroxylation,a hydroxylation that has midazolam as input and 1'-hydroxymidazolam as output,None
http://purl.org/obo/owl/GO#GO_0003674,molecular_function,None,None
http://purl.obolibrary.org/obo/PR_000001891,multidrug resistance protein 1,None,None
http://purl.obolibrary.org/obo/DIDEO_00000016,narrow therapeutic index,"A disposition inhering in a drug product that when realized is realized by processes that negatively affect the safety or the efficacy of the drug product, or increase its toxicity..",None
http://purl.obolibrary.org/obo/DIDEO_00000121,net flux ratio,None,None
http://purl.obolibrary.org/obo/DIDEO_00000173,nifedipine dehydrogenation,a dehydrogenation that has nifedipine as input and has dehydronifedipine as output,None
http://purl.obolibrary.org/obo/DIDEO_00000184,number of doses in a day,a count of administrations of a substance to an organism over a duration of 24 hours,None
http://purl.obolibrary.org/obo/DIDEO_00000190,number of liver donors,a count of human beings from whom originate hepatocytes to be used in an investigation,Number of Livers
http://purl.obolibrary.org/obo/DIDEO_00000011,object drug information,An information content entity that makes a statement about a drug product being an object drug in a drug interaction.,None
http://purl.obolibrary.org/obo/DIDEO_00000012,object drug role,The role that inheres in a drug product or drug ingredient and that is realized by being affected by another drug pharmacokinetically or pharmacodynamically in a drug drug interaction.,None
http://purl.obolibrary.org/obo/OBI_0300311,observation design,observation design is a study design in which subjects are monitored in the absence of any active intervention by experimentalists.,None
http://purl.obolibrary.org/obo/DIDEO_00000003,observational data item about drug-drug interaction,A data item that is about a drug-drug interaction and the creation of which was triggered by an observation outside a controlled context (e.g. a clinical trial).,None
http://purl.obolibrary.org/obo/DIDEO_00000048,obsolete_evidence information content entity,None,None
http://purl.obolibrary.org/obo/DIDEO_00000175,omeprazole 5-hydroxylation,a hydroxylation that has omeprazole as input and has 5-hydroxyomeprazole as output,None
http://purl.obolibrary.org/obo/OBI_0100026,organism,"A material entity that is an individual living system, such as animal, plant, bacteria or virus, that is capable of replicating or reproducing, growth and maintenance in the right environment. An organism may be unicellular or made up, like humans, of many billions of cells divided into specialized tissues and organs.",None
http://purl.obolibrary.org/obo/DIDEO_00000177,paclitaxel 6-alpha hydroxylation,a hydroxylation that has paclitaxel as input and 6-alpha-hydroxypaclitaxel as output,None
http://purl.obolibrary.org/obo/OBI_0500006,parallel group design,"A parallel group design or independent measure design is a study design which uses unique experimental unit each experimental group, in other word no two individuals are shared between experimental groups, hence also known as parallel group design. Subjects of a treatment group receive a unique combination of independent variable values making up a treatment",independent measure design
http://purl.obolibrary.org/obo/DIDEO_00000170,percent inhibition,a measurement datum that describes the decrease in activity of a transporter or enzyme in the presence of a compound from activity in the control experiment,% inhibition
http://purl.obolibrary.org/obo/DIDEO_00000046,pharmacokinetic area under curve,An area under curve in a plot of concentration of granular part of a drug product in some matrix (medium) against time.,None
http://purl.obolibrary.org/obo/DIDEO_00000049,pharmacokinetic area under curve information,None,AUC information
http://purl.obolibrary.org/obo/DIDEO_00000009,pharmacokinetic interaction signal,"A data item that is the outcome of running a kinetic model and that states that drug A has some effects on the absorption, metabolism and elimination of drug B.",None
http://purl.obolibrary.org/obo/DIDEO_00000095,pharmacokinetic parameter ratio,An information content entity that describes the relationship between the mean (arithmetic and geometric) of measurements of a pharmacokintect parameter for a given drug A in absence of another drug and the mean (arithmetic and geometric) of measurements of a pharmacokintect parameter for a given drug A coadministrated with another drug B.,None
http://purl.obolibrary.org/obo/DIDEO_00000097,pharmacokinetic parameter ratio decrease,An pharmacokinetic parameter directionality that describes negative relationship between the numbers of the ratio.,None
http://purl.obolibrary.org/obo/DIDEO_00000092,pharmacokinetic parameter ratio directionality,An information content entity that is part of a pharmacokinetic parameter ratio and that describes whether the relationship between the numbers of the ratio is a positive or a negative one.,None
http://purl.obolibrary.org/obo/DIDEO_00000098,pharmacokinetic parameter ratio increase,An pharmacokinetic parameter directionality that describes positive relationship between the numbers of the ratio.,None
http://purl.obolibrary.org/obo/DIDEO_00000052,pharmacokinetic process,"A biological process that has as a participant a part of a drug product and includes absorption, distribution, metabolism and excretion of that substance.",None
http://purl.obolibrary.org/obo/DIDEO_00000178,phenacetin O-deethylation,a deethylation that has phenacetin as input and acetaminophen as output,None
http://purl.obolibrary.org/obo/DIDEO_00000004,physiological observation from clinical study data item,A data item that is about a biological process and that is the specified output of a clinical study.,None
http://purl.obolibrary.org/obo/DIDEO_00000166,pooled human intestinal microsomal fraction,"a processed material that has a centrifuge pellet role resulting from centrifugation of a human intestine S9 fraction, which is derived from multiple donors, at 104,000 g",pooled human intestinal microsomes
http://purl.obolibrary.org/obo/DIDEO_00000164,pooled human liver microsomal fraction,"a processed material that has a centrifuge pellet role resulting from centrifugation at 104,000 g of a human liver S9 fraction, which is derived from multiple donors",pooled human liver microsomes
http://purl.obolibrary.org/obo/DIDEO_00000000,potential drug-drug interaction,"A potential drug-drug interaction (PDDI) is an information content entity that specifies the possibility of a drug-drug interaction based on either reasonable extrapolation about drug-drug interaction mechanisms or a data item created by clinical studies, clinical observation or physiological experiment.",None
http://purl.obolibrary.org/obo/DIDEO_00000014,precipitant drug information,An information content entity that makes a statement about a drug product being an precipitant drug in a drug interaction.,None
http://purl.obolibrary.org/obo/DIDEO_00000013,precipitant drug role,The role that inheres in a drug product or drug ingredient that is realized by affecting another drug pharmacokinetically or pharmacodynamically in a drug drug interaction.,None
http://purl.obolibrary.org/obo/DIDEO_00000040,primary metabolic clearance enzyme role,None,None
http://purl.obolibrary.org/obo/DIDEO_00000039,primary total clearance enzyme role,A role that is borne by the enzyme responsible for 50% or more of the active pharmaceutic ingredient or metabolite’s total clearance from the body. The role role is realized by the metabolic process of the active pharmaceutical ingredient or metabolite.,None
http://purl.obolibrary.org/obo/DIDEO_00000123,probe subtrate role,"The role that inheres in a chemical substance and that, if realized, is realized by a single, specified metabolic or transport reaction, which is being affected by another chemically substance pharmacokinetically in a drug-drug interaction experiment or natural product-drug interaction.",None
http://purl.obolibrary.org/obo/OBI_0000047,processed material,Is a material entity that is created or changed during material processing.,None
http://purl.obolibrary.org/obo/OBI_0000272,protocol,"A plan specification which has sufficient level of detail and quantitative information to communicate it between investigation agents, so that different investigation agents will reliably be able to independently reproduce the process.",None
http://purl.obolibrary.org/obo/DIDEO_00000082,public adverse event reporting database,A data set that is structured and stored on a computer and that is publicly available and contains reports of adverse events.,None
http://purl.obolibrary.org/obo/DIDEO_00000183,recombinant protein production host role,"a target of material addition role that is borne by a cultured cell and, if realized, is realized in recombinant protein production",None
http://purl.obolibrary.org/obo/DIDEO_00000094,renal clearance ratio,"A pharmacokinetic parameter ratio that describes the relation between the measurement of the volume of blood, serum, or plasma from which an active ingredient or a metabolite is completely removed by the kidney in a given amount of time in an organism with and without the inhibiting drug present in the organism.",CL_R ratio
http://purl.obolibrary.org/obo/DIDEO_00000008,reported drug-drug interaction,A drug-drug interaction that has been the subject of a case report or study.,interaction occured
http://purl.obolibrary.org/obo/DRON_00000030,role of scattered molecular aggregate,a role borne by a scattered molecular aggregate and realized by its grains participating in one or more processes,None
http://purl.obolibrary.org/obo/DIDEO_00000154,sandwich cultured hepatocyte population,"a cultured cell population derived from hepatocytes, in which, during the culturing process, the cells occupy a region bound by two parallel plates made of gelled collagen",None
http://purl.obolibrary.org/obo/OBI_0000576,scattered molecular aggregate,A scattered molecular aggregate is a material entity that consists of all the molecules of a specific type that are located in some bounded region and which is part of a more massive material entity that has parts that are other such aggregates,Collective
http://purl.obolibrary.org/obo/DIDEO_00000188,siRNA knockout Caco-2 cell,a Caco-2 cell that is a specified output of a gene knockout that has specified input siRNA,None
http://purl.obolibrary.org/obo/OBI_0100051,specimen,A material entity that has the specimen role.,None
http://purl.obolibrary.org/obo/OBI_0500000,study design,A plan specification comprised of protocols (which may specify how and what kinds of data will be gathered) that are executed as part of an investigation and is realized during a study design execution.,experimental design
http://purl.obolibrary.org/obo/OBI_0000034,supernatant role,supernatant role is a role which inheres in a material entity and is realized by a material separation process using gravitational force in which the material bearing the supernatant role is the liquid component of the output material.,None
http://purl.obolibrary.org/obo/OBI_0000444,target of material addition role,target of material addition role is a role realized by an entity into which a material is added in a material addition process,None
http://purl.obolibrary.org/obo/DIDEO_00000180,testosterone 6-beta-hydroxylation,a hydroxylation that has testosterone as input and 6-beta-hydroxytestosterone as output,None
http://purl.obolibrary.org/obo/DIDEO_00000119,time to maximum drug concentration ratio,None,Tmax ratio
http://purl.obolibrary.org/obo/OBI_0001479,tissue specimen,"A specimen that derives from an anatomical part or substance arising from an organism. Examples of tissue specimen include tissue, organ, physiological system, blood, or body location (arm).",None
http://purl.obolibrary.org/obo/OBI_0001152,transfection,"a genetic transformation which relies on the use of physical, electrical and chemical phenomena to introduce DNA or RNA into a cell",None
http://purl.obolibrary.org/obo/DIDEO_00000153,transgenic animal hepatocyte population,a cultured cell population that is derived from cells isolated from the liver of a transgenic organism,None
http://purl.obolibrary.org/obo/DIDEO_00000118,volume of distribution ratio,None,None
